Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

MLA

Fraquelli, Mirella, et al. “Contrast-Enhanced Ultrasound for the Diagnosis of Hepatocellular Carcinoma in Adults with Chronic Liver Disease.” The Cochrane Database of Systematic Reviews, vol. 9, Sept. 2022, p. CD013483. EBSCOhost, https://doi.org/10.1002/14651858.CD013483.pub2.

APA

Fraquelli, M., Nadarevic, T., Colli, A., Manzotti, C., Giljaca, V., Miletic, D., Štimac, D., & Casazza, G. (2022). Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. The Cochrane Database of Systematic Reviews, 9, CD013483. https://doi.org/10.1002/14651858.CD013483.pub2

Chicago

Fraquelli, Mirella, Tin Nadarevic, Agostino Colli, Cristina Manzotti, Vanja Giljaca, Damir Miletic, Davor Štimac, and Giovanni Casazza. 2022. “Contrast-Enhanced Ultrasound for the Diagnosis of Hepatocellular Carcinoma in Adults with Chronic Liver Disease.” The Cochrane Database of Systematic Reviews 9 (September): CD013483. doi:10.1002/14651858.CD013483.pub2.